BIND Therapeutics and Synergy Pharmaceuticals Partner for Development of ACCURINS® Biotech Investing
NanoViricides Signs Agreement with University of Pittsburg for Ocular Testing of Its Drug Candidates Pharmaceutical Investing
Nano Dimension Interview: Ground Breaking 3D Printer is a Game Changer for Chip Makers Emerging Technology Investing
Nano Dimension Puts 3D Printed Electronics in the Spotlight at SOLIDWORKS World 2016 Emerging Technology Investing
NanoViricides Signs Agreement with the University of Wisconsin for Testing of Anti-Viral Candidates Pharmaceutical Investing
Nano Dimension Adds More Than $800,000 to the Balance Sheet as Founders Exercise Options Emerging Technology Investing
